Michael Lebens

3.3k total citations
63 papers, 2.0k citations indexed

About

Michael Lebens is a scholar working on Endocrinology, Immunology and Molecular Biology. According to data from OpenAlex, Michael Lebens has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Endocrinology, 21 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Michael Lebens's work include Escherichia coli research studies (41 papers), Vibrio bacteria research studies (21 papers) and Glycosylation and Glycoproteins Research (11 papers). Michael Lebens is often cited by papers focused on Escherichia coli research studies (41 papers), Vibrio bacteria research studies (21 papers) and Glycosylation and Glycoproteins Research (11 papers). Michael Lebens collaborates with scholars based in Sweden, France and United States. Michael Lebens's co-authors include Jan Holmgren, Ann‐Mari Svennerholm, Joshua Tobias, Susann Teneberg, Cécil Czerkinsky, Malin Bäckström, Annie George‐Chandy, Marianne Lindblad, Peter A. Williams and Erik Nygren and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Biotechnology.

In The Last Decade

Michael Lebens

63 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Lebens Sweden	27	826	756	528	472	253	63	2.0k
Birgid Neumeister Germany	22	585 0.7×	459 0.6×	1.0k 1.9×	531 1.1×	244 1.0×	53	2.1k
Josette Arondel France	18	1.1k 1.3×	582 0.8×	694 1.3×	802 1.7×	286 1.1×	24	2.2k
Hidenori Matsui Japan	26	540 0.7×	641 0.8×	681 1.3×	448 0.9×	286 1.1×	114	2.4k
Armando Navarro Mexico	21	931 1.1×	587 0.8×	319 0.6×	586 1.2×	116 0.5×	90	2.1k
Myriam Tanguy France	15	330 0.4×	490 0.6×	627 1.2×	514 1.1×	263 1.0×	18	1.8k
P J Sansonetti France	18	906 1.1×	303 0.4×	356 0.7×	639 1.4×	303 1.2×	35	1.7k
Saeid Bouzari Iran	25	874 1.1×	232 0.3×	591 1.1×	594 1.3×	137 0.5×	139	2.0k
Martin Handfield United States	26	431 0.5×	427 0.6×	794 1.5×	369 0.8×	203 0.8×	49	2.3k
Andrew J. Olive United States	23	508 0.6×	685 0.9×	577 1.1×	619 1.3×	377 1.5×	47	2.1k
Shingo Yamamoto Japan	22	1.0k 1.3×	649 0.9×	365 0.7×	377 0.8×	105 0.4×	49	2.1k

Countries citing papers authored by Michael Lebens

Since Specialization

Citations

This map shows the geographic impact of Michael Lebens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lebens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lebens more than expected).

Fields of papers citing papers by Michael Lebens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lebens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lebens. The network helps show where Michael Lebens may publish in the future.

Co-authorship network of co-authors of Michael Lebens

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lebens. A scholar is included among the top collaborators of Michael Lebens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lebens. Michael Lebens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiangkun, Karin Schön, Yane Jia, et al.. (2025). Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection. Nature Communications. 16(1). 432–432. 7 indexed citations

Wallom, Kerri‐Lee, et al.. (2023). Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands. Glycobiology. 33(10). 801–816. 6 indexed citations

Holmgren, Jan, et al.. (2018). Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant. Vaccine. 36(41). 6223–6230. 38 indexed citations

Wands, Amberlyn M., Anna Casselbrant, Aleksander Cvjetkovic, et al.. (2018). GM1 ganglioside-independent intoxication by Cholera toxin. PLoS Pathogens. 14(2). e1006862–e1006862. 55 indexed citations

Rattik, Sara, Ingrid Yao Mattisson, Irena Ljungcrantz, et al.. (2018). B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice. Vascular Pharmacology. 111. 54–61. 6 indexed citations

Tobias, Joshua, Michael Lebens, Sun Nyunt Wai, Jan Holmgren, & Ann‐Mari Svennerholm. (2017). Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae , enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens. Microbial Pathogenesis. 105. 177–184. 23 indexed citations

Lebens, Michael, et al.. (2016). Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae. Vaccine. 34(18). 2121–2128. 34 indexed citations

Tobias, Joshua, Ann‐Mari Svennerholm, Nils Carlin, Michael Lebens, & Jan Holmgren. (2011). Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice. Vaccine. 29(48). 8863–8869. 24 indexed citations

Tobias, Joshua, Ann‐Mari Svennerholm, Jan Holmgren, & Michael Lebens. (2010). Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines. Applied Microbiology and Biotechnology. 87(4). 1355–1365. 17 indexed citations

10.

Tobias, Joshua, Jan Holmgren, Maria Hellman, et al.. (2010). Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria. Vaccine. 28(43). 6977–6984. 20 indexed citations

11.

Holmner, Åsa, Michael Lebens, Susann Teneberg, et al.. (2007). Novel Binding Site Identified in a Hybrid between Cholera Toxin and Heat-Labile Enterotoxin: 1.9 Å Crystal Structure Reveals the Details. Structure. 15(2). 253–253. 1 indexed citations

12.

Raghavan, Sukanya, et al.. (2006). Oral tolerance induction by mucosal administration of cholera toxin B‐coupled antigen involves T‐cell proliferation in vivo and is not affected by depletion of CD25⁺ T cells. Immunology. 118(3). 311–320. 20 indexed citations

13.

Anjuère, Fabienne, Carmelo Luci, Michael Lebens, et al.. (2004). In Vivo Adjuvant-Induced Mobilization and Maturation of Gut Dendritic Cells after Oral Administration of Cholera Toxin. The Journal of Immunology. 173(8). 5103–5111. 78 indexed citations

14.

Holmgren, Jan, Jenni Adamsson, Fabienne Anjuère, et al.. (2004). Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunology Letters. 97(2). 181–188. 178 indexed citations

15.

Holmner, Åsa, Michael Lebens, Susann Teneberg, et al.. (2004). Novel Binding Site Identified in a Hybrid between Cholera Toxin and Heat-Labile Enterotoxin. Structure. 12(9). 1655–1667. 34 indexed citations

16.

Hamid, M., Søren Bregenholt, Dale R. Wegmann, et al.. (2002). Genetic fusion of human insulin B‐chain to the B‐subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Immunology. 106(2). 237–245. 27 indexed citations

17.

Hernández, Héctor J., Laura I. Rutitzky, Michael Lebens, Jan Holmgren, & Miguel J. Stadecker. (2002). Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B‐immunodominant peptide conjugate correlates with enhanced transforming growth factor‐β production by CD4 T cells. Parasite Immunology. 24(8). 423–427. 16 indexed citations

18.

Bäckström, Malin, Vafa Shahabi, Susann Teneberg, et al.. (1997). Structural basis for differential receptor binding of cholera and Escherichia coli heat‐labile toxins: influence of heterologous amino acid substitutions in the cholera B‐subunit. Molecular Microbiology. 24(3). 489–497. 27 indexed citations

19.

Czerkinsky, Cécil, Jiabin Sun, Michael Lebens, et al.. (1996). Cholera Toxin B Subunit as Transmucosal Carrier‐Delivery and Immunomodulating System for Induction of Antiinfectious and Antipathological Immunitya. Annals of the New York Academy of Sciences. 778(1). 185–193. 28 indexed citations

20.

Lebens, Michael & Jan Holmgren. (1994). Structure and arrangement of the cholera toxin genes inVibrio choleraeO139. FEMS Microbiology Letters. 117(2). 197–202. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact